259 related articles for article (PubMed ID: 1054537)
1. Platelet function in patients with high platelet counts.
Ginsburg AD
Ann Intern Med; 1975 Apr; 82(4):506-11. PubMed ID: 1054537
[TBL] [Abstract][Full Text] [Related]
2. Platelets in myeloproliferative disorders. I. A comparative evaluation with certain platelet function tests.
Boneu B; Nouvel C; Sie P; Caranobe C; Combes D; Laurent G; Pris J; Bierme R
Scand J Haematol; 1980 Sep; 25(3):214-20. PubMed ID: 7466310
[TBL] [Abstract][Full Text] [Related]
3. Template bleeding time and clinical hemorrhage in myeloproliferative disease.
Murphy S; Davis JL; Walsh PN; Gardner FH
Arch Intern Med; 1978 Aug; 138(8):1251-3. PubMed ID: 277084
[TBL] [Abstract][Full Text] [Related]
4. Evidence for a platelet membrane defect in the myeloproliferative syndromes.
Castaldi PA; Berndt MC; Booth W; Gregory C; Bull H; Greaves M
Thromb Res; 1982 Sep; 27(5):601-9. PubMed ID: 6960545
[TBL] [Abstract][Full Text] [Related]
5. The diagnostic value of the serum lactic dehydrogenase determination in the evaluation of unexplained thrombocytosis.
Budman DR; Lackner H; Berczeller P; Silber R
Am J Clin Pathol; 1981 Jun; 75(6):840-3. PubMed ID: 6942650
[TBL] [Abstract][Full Text] [Related]
6. Platelet and fibrinogen kinetics in the chronic myeloproliferative disorders.
Brodsky I; Kahn SB; Ross EM; Petkov G
Cancer; 1972 Dec; 30(6):1444-50. PubMed ID: 4509103
[No Abstract] [Full Text] [Related]
7. Simultaneous study of platelets and phagocytes in myeloproliferative disorders.
Laharrague PF; Corberand JX; Fillola G; Boneu BP; Pris JF
Biomed Pharmacother; 1984; 38(9-10):462-5. PubMed ID: 6597727
[TBL] [Abstract][Full Text] [Related]
8. Thrombohaemorrhagic complications in 101 cases of myeloproliferative disorders: relationship to platelet number and function.
Barbui T; Cortelazzo S; Viero P; Bassan R; Dini E; Semeraro N
Eur J Cancer Clin Oncol; 1983 Nov; 19(11):1593-9. PubMed ID: 6580171
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of beta-thromboglobulin in patients with high platelet count.
Fabris F; Randi ML; Casonato A; Dal Bo Zanon R; Bonvicini P; Girolami A
Acta Haematol; 1984; 71(1):32-8. PubMed ID: 6197855
[TBL] [Abstract][Full Text] [Related]
10. Spontaneous platelet aggregation in myeloproliferative disorders. A preliminary study.
Barbui T; Battista R; Dini E
Acta Haematol; 1973; 50(1):25-9. PubMed ID: 4200801
[No Abstract] [Full Text] [Related]
11. Measurement of platelet life-span in normal subjects and patients with myeloproliferative disease with indium oxine labelled platelets.
Bautista AP; Buckler PW; Towler HM; Dawson AA; Bennett B
Br J Haematol; 1984 Dec; 58(4):679-87. PubMed ID: 6240280
[TBL] [Abstract][Full Text] [Related]
12. Platelet defects in the myeloproliferative disorders.
Inceman S; Tangün Y
Ann N Y Acad Sci; 1972 Oct; 201():251-61. PubMed ID: 4509685
[No Abstract] [Full Text] [Related]
13. Platelet 5-hydroxytryptamine transport and storage in myeloproliferative disorders.
Cortellazzo S; Viero P; Buczko W; Barbui T; de Gaetano G
Scand J Haematol; 1985 Feb; 34(2):146-51. PubMed ID: 3856312
[TBL] [Abstract][Full Text] [Related]
14. Thrombocytosis and thrombocythaemia.
Murphy S
Clin Haematol; 1983 Feb; 12(1):89-106. PubMed ID: 6340888
[No Abstract] [Full Text] [Related]
15. Qualitative platelet defects in chronic myeloproliferative disorders: evidence for reduced ATP secretion.
Löfvenberg E; Nilsson TK
Eur J Haematol; 1989 Nov; 43(5):435-40. PubMed ID: 2612617
[TBL] [Abstract][Full Text] [Related]
16. Flow cytometric analysis of megakaryocyte ploidy in chronic myeloproliferative disorders and reactive thrombocytosis.
Jacobsson S; Carneskog J; Ridell B; Wadenvik H; Swolin B; Kutti J
Eur J Haematol; 1996 May; 56(5):287-92. PubMed ID: 8641402
[TBL] [Abstract][Full Text] [Related]
17. The myeloproliferative disorders.
Gilbert HS; Dameshek W
Dis Mon; 1970 Oct; ():1-52. PubMed ID: 4921953
[No Abstract] [Full Text] [Related]
18. Platelet aggregation and platelet factor 3 activity in myeloproliferative disorders.
Tangün Y
Thromb Diath Haemorrh; 1971 Jun; 25(2):241-51. PubMed ID: 5284903
[No Abstract] [Full Text] [Related]
19. Platelet survival, platelet factor-4 and bleeding time in myeloproliferative disorders.
Berild D; Hasselbalch H; Knudsen JB
Scand J Clin Lab Invest; 1987 Sep; 47(5):497-501. PubMed ID: 3477851
[TBL] [Abstract][Full Text] [Related]
20. [Megakaryocytopoiesis in myeloproliferative disorders].
Podolak-Dawidziak M
Acta Haematol Pol; 1992; 23(2 Suppl 1):19-22. PubMed ID: 1488868
[No Abstract] [Full Text] [Related]
[Next] [New Search]
